|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4500 NZD | +7.14% |
|
+5.88% | -29.69% |
| 05-05 | New Zealand Shares Fall; Fletcher Building Flags Ongoing Residential Review, Asset Sales Underway | MT |
| 05-05 | Synlait Milk provides banking facilities update | RE |
| Fiscal Period: July | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -0.84 | 2.13 | 0.31 | -3.07 | -0.83 | |||||
Return on Total Capital | -1.08 | 2.83 | 0.42 | -3.91 | -1.06 | |||||
Return On Equity % | -4.15 | 5.08 | -1.84 | -26.11 | -5.72 | |||||
Return on Common Equity | -4.15 | 5.08 | -1.84 | -26.11 | -5.72 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 4.92 | 8.84 | 8.93 | 3.42 | 5.76 | |||||
SG&A Margin | 6.46 | 5.56 | 8.32 | 8.19 | 6.88 | |||||
EBITDA Margin % | 1.92 | 6.15 | 4.13 | -1.85 | 1.34 | |||||
EBITA Margin % | -1.5 | 3.31 | 0.64 | -4.76 | -1.02 | |||||
EBIT Margin % | -1.53 | 3.28 | 0.61 | -4.76 | -1.11 | |||||
Income From Continuing Operations Margin % | -2.08 | 2.32 | -1.07 | -11.13 | -2.18 | |||||
Net Income Margin % | -2.08 | 2.32 | -0.32 | -11.13 | -2.18 | |||||
Net Avail. For Common Margin % | -2.08 | 2.32 | -1.07 | -11.13 | -2.18 | |||||
Normalized Net Income Margin | -1.72 | 1.67 | -0.77 | -4.4 | -1.55 | |||||
Levered Free Cash Flow Margin | -12.33 | 9.97 | -17.7 | 1.01 | 5.29 | |||||
Unlevered Free Cash Flow Margin | -11.39 | 10.68 | -16.31 | 2.83 | 6.65 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.88 | 1.04 | 0.81 | 1.03 | 1.2 | |||||
Fixed Assets Turnover | 1.35 | 1.6 | 1.27 | 1.65 | 1.95 | |||||
Receivables Turnover (Average Receivables) | 17.74 | 18.39 | 16.79 | 18.84 | 23.41 | |||||
Inventory Turnover (Average Inventory) | 4.81 | 6.01 | 4.98 | 6.87 | 7.01 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.45 | 0.84 | 0.9 | 0.63 | 0.68 | |||||
Quick Ratio | 0.47 | 0.25 | 0.16 | 0.25 | 0.25 | |||||
Operating Cash Flow to Current Liabilities | 0.05 | 0.53 | 0.06 | -0.07 | 0.23 | |||||
Days Sales Outstanding (Average Receivables) | 20.58 | 19.85 | 21.74 | 19.43 | 15.59 | |||||
Days Outstanding Inventory (Average Inventory) | 75.85 | 60.75 | 73.31 | 53.24 | 52.05 | |||||
Average Days Payable Outstanding | 29.17 | 29.87 | 48.83 | 33.99 | 29.65 | |||||
Cash Conversion Cycle (Average Days) | 67.25 | 50.72 | 46.23 | 38.68 | 37.99 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 66.21 | 51.25 | 61.23 | 101.69 | 48.69 | |||||
Total Debt / Total Capital | 39.84 | 33.88 | 37.98 | 50.42 | 32.75 | |||||
LT Debt/Equity | 61.45 | 42.8 | 27.92 | 39.52 | 6.18 | |||||
Long-Term Debt / Total Capital | 36.97 | 28.3 | 17.32 | 19.59 | 4.16 | |||||
Total Liabilities / Total Assets | 52.59 | 52.51 | 53.11 | 59.52 | 49.56 | |||||
EBIT / Interest Expense | -1.02 | 2.91 | 0.27 | -1.64 | -0.51 | |||||
EBITDA / Interest Expense | 1.51 | 5.68 | 2.05 | -0.47 | 0.78 | |||||
(EBITDA - Capex) / Interest Expense | -4.16 | 2.62 | 0.38 | -1.07 | 0.2 | |||||
Total Debt / EBITDA | 16.38 | 3.61 | 8.06 | -27.29 | 12.38 | |||||
Net Debt / EBITDA | 15.86 | 3.47 | 7.91 | -26.84 | 9.85 | |||||
Total Debt / (EBITDA - Capex) | -5.97 | 7.81 | 43.94 | -12.04 | 47.42 | |||||
Net Debt / (EBITDA - Capex) | -5.78 | 7.52 | 43.1 | -11.84 | 37.75 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 5.02 | 21.45 | -5.46 | 2.08 | 11.64 | |||||
Gross Profit, 1 Yr. Growth % | -66.96 | 118.07 | -5.09 | -61.1 | 88.06 | |||||
EBITDA, 1 Yr. Growth % | -83.92 | 296.44 | -41.87 | -144.65 | -185.64 | |||||
EBITA, 1 Yr. Growth % | -116.64 | -360.3 | -81.84 | -456.19 | -75.47 | |||||
EBIT, 1 Yr. Growth % | -117.03 | -353.57 | -82.59 | -463.09 | -73.92 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -138.29 | -235.4 | -135.03 | 4.14K | -78.13 | |||||
Net Income, 1 Yr. Growth % | -138.29 | -235.4 | -111.14 | 4.14K | -78.13 | |||||
Normalized Net Income, 1 Yr. Growth % | -136.15 | -216.38 | -143.26 | 4.95K | -60.79 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -133.3 | -227.66 | -135.11 | 4.14K | -91.13 | |||||
Accounts Receivable, 1 Yr. Growth % | 77.74 | -16.97 | -7.91 | 30.35 | -41.19 | |||||
Inventory, 1 Yr. Growth % | 0.58 | -14.03 | 7.43 | -16.2 | 34.2 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 5.85 | -0.01 | -0.56 | -8.44 | -2.58 | |||||
Total Assets, 1 Yr. Growth % | 8.64 | -2.61 | 6.96 | -11.37 | 4.68 | |||||
Tangible Book Value, 1 Yr. Growth % | 28.86 | -8.32 | 19.82 | -33.37 | 40.21 | |||||
Common Equity, 1 Yr. Growth % | 26.9 | -2.44 | 5.61 | -23.48 | 30.42 | |||||
Cash From Operations, 1 Yr. Growth % | -84.71 | 1.17K | -83.24 | -220.89 | -450.75 | |||||
Capital Expenditures, 1 Yr. Growth % | -16.56 | -50.75 | -14.31 | -41.78 | -19.64 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 14.16 | -196.58 | -244.09 | -107.25 | 487.16 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 15.12 | -211.75 | -225.15 | -122.35 | 162.53 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 15.54 | 12.93 | -1.72 | 8.24 | 6.75 | |||||
Gross Profit, 2 Yr. CAGR % | -39.9 | -15.12 | 32.36 | -32.85 | -14.47 | |||||
EBITDA, 2 Yr. CAGR % | -58.16 | -20.97 | 45.54 | -43.12 | -39.89 | |||||
EBITA, 2 Yr. CAGR % | -59.36 | -33.33 | -36.62 | 29.32 | -7.53 | |||||
EBIT, 2 Yr. CAGR % | -58.93 | -33.47 | -38.8 | 29.84 | -2.69 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -41.18 | -28 | -29.49 | 112.38 | 204.6 | |||||
Net Income, 2 Yr. CAGR % | -41.18 | -28 | -61.16 | 117.42 | 204.6 | |||||
Normalized Net Income, 2 Yr. CAGR % | -43.34 | -34.68 | -34.67 | 75.11 | 344.95 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -45.15 | -34.8 | -31.45 | 112.62 | 94 | |||||
Accounts Receivable, 2 Yr. CAGR % | 30.78 | 21.48 | -12.56 | 9.56 | -12.44 | |||||
Inventory, 2 Yr. CAGR % | 28.2 | -7.01 | -3.89 | -5.12 | 6.04 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 10.99 | 2.88 | -0.29 | -4.59 | -5.56 | |||||
Total Assets, 2 Yr. CAGR % | 18.6 | 2.86 | 2.06 | -2.64 | -3.68 | |||||
Tangible Book Value, 2 Yr. CAGR % | 17 | 8.69 | 4.81 | -10.65 | -3.34 | |||||
Common Equity, 2 Yr. CAGR % | 24.82 | 11.27 | 1.5 | -10.1 | -0.1 | |||||
Cash From Operations, 2 Yr. CAGR % | -65.91 | 49.83 | 45.68 | -54.99 | 105.92 | |||||
Capital Expenditures, 2 Yr. CAGR % | -38.72 | -35.9 | -35.04 | -29.37 | -31.6 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -5.82 | 5.89 | 16.76 | -68.15 | -34.75 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -8.12 | 14.46 | 16.53 | -48.16 | -23.41 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 15.87 | 17.47 | 0.48 | 6.18 | 9.37 | |||||
Gross Profit, 3 Yr. CAGR % | -26.05 | -7.65 | -16.67 | -5.94 | -5.35 | |||||
EBITDA, 3 Yr. CAGR % | -42.18 | -12.06 | -30.64 | 5.63 | -36.04 | |||||
EBITA, 3 Yr. CAGR % | -43.22 | -23.88 | -59.07 | 54.65 | -26.23 | |||||
EBIT, 3 Yr. CAGR % | -42.83 | -24.02 | -59.71 | 53.65 | -23.96 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -27.47 | -22.34 | -42.48 | 85.67 | -0.46 | |||||
Net Income, 3 Yr. CAGR % | -27.47 | -22.34 | -61.35 | 85.67 | 1.11 | |||||
Normalized Net Income, 3 Yr. CAGR % | -29.03 | -27.64 | -46.12 | 44.62 | 6.33 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -30.82 | -27.31 | -46.11 | 82.21 | -26.26 | |||||
Accounts Receivable, 3 Yr. CAGR % | 28.44 | 12.4 | 10.77 | -0.11 | -10.96 | |||||
Inventory, 3 Yr. CAGR % | 23.06 | 12.22 | -2.43 | -8.19 | 6.5 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 24.64 | 7.19 | 1.72 | -3.08 | -3.92 | |||||
Total Assets, 3 Yr. CAGR % | 26.8 | 11.06 | 4.21 | -2.63 | -0.26 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.92 | 7.87 | 12.28 | -9.88 | 3.83 | |||||
Common Equity, 3 Yr. CAGR % | 21.78 | 14.98 | 9.35 | -7.62 | 1.77 | |||||
Cash From Operations, 3 Yr. CAGR % | -45.57 | 19.48 | -27.81 | 36.9 | -10.76 | |||||
Capital Expenditures, 3 Yr. CAGR % | 1.71 | -43.03 | -29.39 | -37.37 | -26.26 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 81.68 | -4.49 | 16.54 | -54.21 | -15.86 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 90.57 | -1.33 | 16.76 | -33.69 | -10.97 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 20.12 | 16.95 | 8.48 | 9.83 | 7.01 | |||||
Gross Profit, 5 Yr. CAGR % | -7.57 | 5.55 | -6.67 | -21.37 | -12.36 | |||||
EBITDA, 5 Yr. CAGR % | -20.59 | 3.15 | -16.69 | -27.37 | -31.55 | |||||
EBITA, 5 Yr. CAGR % | -19.73 | -4.05 | -40.36 | -8.92 | -31.43 | |||||
EBIT, 5 Yr. CAGR % | -19.4 | -4.17 | -40.96 | -8.9 | -30.25 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -3.72 | -0.51 | -28.28 | 17.23 | -11.73 | |||||
Net Income, 5 Yr. CAGR % | -3.72 | -0.51 | -43.5 | 17.23 | -11.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | -5.13 | -4.62 | -31.15 | -0.3 | -15.35 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -10.13 | -5.08 | -31.07 | 12.73 | -29.13 | |||||
Accounts Receivable, 5 Yr. CAGR % | 21.92 | 1.1 | 10.13 | 11.26 | 0.82 | |||||
Inventory, 5 Yr. CAGR % | 29.68 | 23.01 | 11.47 | 4.93 | 0.88 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 19.13 | 18.36 | 14 | 2.32 | -1.26 | |||||
Total Assets, 5 Yr. CAGR % | 22.34 | 16.6 | 16.26 | 5.37 | 0.98 | |||||
Tangible Book Value, 5 Yr. CAGR % | 20.55 | 9.78 | 11.34 | 0.04 | 5.75 | |||||
Common Equity, 5 Yr. CAGR % | 24.46 | 14.72 | 13.22 | 4.2 | 5.47 | |||||
Cash From Operations, 5 Yr. CAGR % | -31.4 | 15.12 | -16.88 | -19.14 | 9.79 | |||||
Capital Expenditures, 5 Yr. CAGR % | 23.96 | 11.59 | -14.99 | -37.91 | -30.28 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 32.76 | 18.13 | 52.74 | -38.7 | -8.13 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 37.38 | 17.51 | 57.1 | -24.17 | -2.14 |
- Stock Market
- Equities
- SML Stock
- Financials Synlait Milk Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















